Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Grant or award Head of R&D and CMO acquired 8,000 shares (grant or award)
  2. 4 Open-market buy Director bought 2,500 shares at $16.00 ($40,000)
  3. 4 Planned sale Chief Commercial Officer sold 1,085 shares at an average $23.42 ($25,408)
  4. 4 Planned sale Chief Medical Officer sold 5,035 shares at an average $22.95 ($115,546)
  5. 4 Planned sale CEO & President sold 5,658 shares at $18.88 ($106,823)
  6. 4 Planned sale Director sold 2,586,928 shares at an average $25.20 ($65,184,894)
  7. 4 Planned sale Chief Commercial Officer sold 226 shares at $26.28 ($5,939)
  8. 4 Planned sale Chief Medical Officer sold 1,556 shares at $26.28 ($40,892)
  9. 4 Planned sale CEO & President sold 4,986 shares at $26.28 ($131,032)
  10. 4 Planned sale Chief Financial Officer sold 1,797 shares at $26.28 ($47,225)
  11. 4 Planned sale Director sold 261,460 shares at an average $25.51 ($6,670,769)
  12. 4 Planned sale Director sold 777,451 shares at an average $22.97 ($17,858,492)
  13. 4 Planned sale Director sold 504,695 shares at an average $21.23 ($10,712,550)
  14. 4 Open-market sale Chief Financial Officer sold 2,362 shares at $20.37 ($48,114)
  15. 4 Planned sale Director sold 267,760 shares at an average $21.09 ($5,646,497)
  16. 4 Planned sale Director sold 263,962 shares at an average $20.70 ($5,464,611)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Planned sale Director sold 84,355 shares at an average $20.10 ($1,695,689)
  20. 4 Planned sale Chief Medical Officer sold 887 shares at $18.33 ($16,259)

Page 1 of 19 · 361 filings